Swissray slaps Elscint with lawsuit

Article

Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated

Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated agreements to distribute Swissray ddR technology internationally and for Swissray to distribute Elscint imaging equipment in Switzerland. The complaint alleges improprieties in Elscint's negotiation tactics, fraudulent concealment of the impending sale of its imaging businesses, and breaches of the distribution agreements following the sale. Swissray turned to the courts because discussions with Elscint failed to resolve these issues, according to Ruedi G. Laupper, Swissray chairman, president, and CEO. Laupper alleges that the distribution agreement with Elscint markedly delayed the deployment of Swissray technology internationally.

Recent Videos
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.